Jaguar Health, Inc. (JAGX)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 7M 14M 21M Q1 '19: 1.6M Q2 '19: 1.7M Q3 '19: 973K Q4 '19: 1.5M Q1 '20: 869K Q2 '20: 3.2M Q3 '20: 2.8M Q4 '20: 2.6M Q3 '23: 2.8M Q4 '23: 2.3M Q1 '24: 2.4M Q2 '24: 2.7M Q3 '24: 3.1M Q4 '24: 3.5M Q1 '25: 2.2M Q2 '25: 3M Q3 '25: 3.1M Q4 '25: 3.2M Q1 '26: 20.3M Q2 '26: 1.2M Q2 '19 Q1 '20 Q4 '20 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

0 7M 14M 21M Q1 '19: 725K Q2 '19: 446K Q3 '19: 25K Q4 '19: 764K Q1 '20: 193K Q2 '20: 2.1M Q3 '20: 2M Q4 '20: 1.8M Q3 '23: 2.3M Q4 '23: 1.6M Q1 '24: 1.9M Q2 '24: 2.3M Q3 '24: 2.6M Q4 '24: 3M Q1 '25: 1.7M Q2 '25: 2.5M Q3 '25: 2.6M Q4 '25: 1M Q1 '26: 19.1M Q2 '26: 194K Q2 '19 Q1 '20 Q4 '20 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '21: -9.5M Q4 '21: -10.8M Q1 '22: -11.8M Q2 '22: -6.5M Q3 '22: -9.9M Q4 '22: -6.3M Q1 '23: -9.8M Q2 '23: -8.1M Q3 '23: -8.8M Q4 '23: -7.6M Q1 '24: -8.2M Q2 '24: -7.2M Q3 '24: -7.3M Q4 '24: -8.2M Q1 '25: -9.4M Q2 '25: -8M Q3 '25: -7.2M Q4 '25: -21.2M Q1 '26: 10.2M Q2 '26: -7.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-24M -16M -8M 0 8M 16M 24M Q3 '21: -12.2M Q4 '21: -14.3M Q1 '22: -18M Q2 '22: -9.4M Q3 '22: -12.5M Q4 '22: -8.2M Q1 '23: -12.2M Q2 '23: -12.2M Q3 '23: -7.8M Q4 '23: -9.3M Q1 '24: -9.2M Q2 '24: -9.5M Q3 '24: -9.9M Q4 '24: -9.9M Q1 '25: -10.5M Q2 '25: -10.4M Q3 '25: -9.5M Q4 '25: -23.2M Q1 '26: 8.7M Q2 '26: -12.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 800K 1.6M 2.4M Q3 '21: 617K Q4 '21: 469K Q1 '22: 455K Q2 '22: 456K Q3 '22: 613K Q4 '22: 495K Q1 '23: 345K Q2 '23: 491K Q3 '23: 514K Q4 '23: 687K Q1 '24: 430K Q2 '24: 427K Q3 '24: 541K Q4 '24: 557K Q1 '25: 515K Q2 '25: 527K Q3 '25: 532K Q4 '25: 2.2M Q1 '26: 1.2M Q2 '26: 1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-12M -8M -4M 0 4M 8M 12M Q3 '21: -9.4M Q4 '21: -8.9M Q1 '22: -7.7M Q2 '22: -10.5M Q3 '22: -8.5M Q4 '22: -6.4M Q1 '23: -9.9M Q2 '23: -9.1M Q3 '23: -6.8M Q4 '23: -7.5M Q1 '24: -7M Q2 '24: -8.2M Q3 '24: -6.3M Q4 '24: -7.8M Q1 '25: -7.3M Q2 '25: -6.2M Q3 '25: -4.7M Q4 '25: -5.5M Q1 '26: 8.8M Q2 '26: -5.3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-10.5M -7M -3.5M 0 3.5M 7M 10.5M Q2 '16: -3.8M Q3 '16: -3.4M Q4 '16: -2.7M Q1 '18: -9.6M Q2 '18: -5.4M Q3 '18: -2.8M Q4 '18: -4.9M Q1 '20: -4.3M Q2 '20: -4M Q3 '20: -2.9M Q4 '20: -4.1M Q3 '21: -9.4M Q4 '21: -8.9M Q3 '22: -8.5M Q4 '22: -6.4M Q1 '23: -9.9M Q2 '23: -9.1M Q3 '23: -6.8M Q3 '24: -6.3M Q4 '24: -7.8M Q3 '16 Q2 '18 Q1 '20 Q4 '20 Q3 '22 Q2 '23 Q4 '24

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 20M 40M 60M Q3 '18: 12.1M Q2 '20: 23.9M Q3 '20: 13.4M Q1 '21: 42.6M Q2 '21: 45M Q3 '21: 45.8M Q1 '22: 778.5K Q2 '22: 1.1M Q3 '22: 1.4M Q1 '23: 5.1M Q2 '23: 293.9K Q3 '23: 345.7K Q1 '24: 105.9K Q2 '24: 3.6M Q3 '24: 374.8K Q1 '25: 17.9K Q2 '25: 29K Q3 '25: 1.5M Q1 '26: 515.8K Q2 '26: 809.1K Q2 '20 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-3000.00 -2000.00 -1000.00 0.00 1000.00 2000.00 3000.00 Q3 '21: -0.77 Q4 '21: -88.21 Q1 '22: -111.03 Q2 '22: -119.49 Q3 '22: -128.05 Q4 '22: -40.26 Q1 '23: -19.55 Q2 '23: -52.13 Q3 '23: -65.80 Q4 '23: -2611.92 Q1 '24: -2696.65 Q2 '24: -2657.96 Q3 '24: -2661.75 Q4 '24: -130.69 Q1 '25: -628.02 Q2 '25: -984.30 Q3 '25: -964.29 Q4 '25: -22.97 Q1 '26: 547.88 Q2 '26: 891.12 Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.